QTc prolongation and torsade de pointes ventricular tachycardia in a small dose voriconazole therapy

European Review for Medical and Pharmacological Sciences

Volumn 16, Issue 1, 2012, Pages 100-102

  Elbey, M A ^a   Cil, H ^a   Onturk, E ^a   Islamoglu, Y ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

QTc prolongation; Torsades de pointes; Voriconazole

Indexed keywords

AMIKACIN; AMPHOTERICIN B; ANTIFUNGAL AGENT; MAGNESIUM SULFATE; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN; VORICONAZOLE; ELECTROLYTE; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ADULT; BLOOD CULTURE; CARDIOVERSION; CASE REPORT; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROLYTE DISTURBANCE; FEMALE; FEVER; HEART ARRHYTHMIA; HEART FUNCTION; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; MEDICAL HISTORY; MITRAL VALVE DISEASE; MITRAL VALVE REGURGITATION; NEPHROTIC SYNDROME; PHYSICAL EXAMINATION; QT PROLONGATION; RESUSCITATION; REVIEW; RHEUMATIC HEART DISEASE; SINUS TACHYCARDIA; TORSADE DES POINTES; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; ELECTROCARDIOGRAPHY; HEART PACING; LONG QT SYNDROME;

ADULT; ANTIFUNGAL AGENTS; CARDIAC PACING, ARTIFICIAL; CARDIOPULMONARY RESUSCITATION; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; ELECTROLYTES; FEMALE; HUMANS; LONG QT SYNDROME; MITRAL VALVE INSUFFICIENCY; NEPHROTIC SYNDROME; PYRIMIDINES; RHEUMATIC HEART DISEASE; TORSADES DE POINTES; TRIAZOLES;

EID: 84859820436     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. PROSSER JM, MILLS A, RHIM ES, PERRONE J. Torsade de pointes caused by polypharmacy and substance abuse in a patient with human immunodeficiency virus. Int J Emerg Med. 2008;1:217-220.
2. WASSMANN S, NICKENIG G, BÖHM M. Long QT syndrome and torsade de pointes in a patient receiving fluconazole. Ann Intern Med 1999;131;797. (Pubitemid 29532004)
3. DE PONTI F, POLLUZI E, CAVELLI A, RECANATINI M, MONTANARO N. Safety of non-arrhythmogenic drugs that prolong the QT interval or induce torsades de pointes. Drug Safety 2002;25:263-286. (Pubitemid 34569360)
4. NELSON MR, SMITH D, ERSKINE D, GAZZARD BG. Ventricular fibrillation secondary to itraconazole induced hyperkalemia. J Infect 1993;26:348. (Pubitemid 23177568)
5. KHAZAN M, MATHIS AS. Probable case of torsades de pointes induced by fluconazole. Pharmacotherapy 2002;22:1632-1637. (Pubitemid 35429958)
6. PASERCHIA LA, HEWETT J, WOOSLEY RL. Effect of ketoconazole on QTc [abstract]. Clin Pharmacol Ther 1994;55:146.
7. MAKKAR RR, FROMM BS, STEINMAN RT, MEISSNER MD, LEHMANN MH. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 1993;270:2590-2597. (Pubitemid 23346699)
8. ALKAN Y, HAEFELI WE, BURHENNE J, STEIN J, YANIV I, SHALIT I. Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect. Clin Infect Dis 2004;39:49-52.
9. EIDEN C, PEYRIERE H, TICHIT R, COCIGLIO M, AMEDRO P, BLAYAC J P, MARGUERITTE G, HILLAIRE-BUYS D. Inherited long QT syndrome revealed by antifungals drugdrug interaction. J Clin Pharm Ther 2007;32:321-324. (Pubitemid 46699512)